Mirae Asset Global Investments’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Mirae Asset Global Investments’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-29,949	Closed	-$722K	–	2749
2023 Q1	$722K	Sell	29,949 -56	-0.2%	-$703	﹤0.01%	1722
2022 Q4	$317K	Buy	30,005 +5,164	+21%	+$41.7K	﹤0.01%	2130
2022 Q3	$112K	Buy	24,841 +7,542	+44%	+$34.4K	﹤0.01%	2477
2022 Q2	$70K	Buy	+17,299	New	+$82K	﹤0.01%	2356

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Mirae Asset Global Investments's PRVB Position: Q2 2023 in Review

Mirae Asset Global Investments sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 29,949 shares — an estimated $722K sold.

Mirae Asset Global Investments first reported a position in PRVB in Q2 2022 and held it in 4 quarters. The position peaked at $722K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Mirae Asset Global Investments reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Mirae Asset Global Investments sold 29,949 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $722K.
Mirae Asset Global Investments first reported a position in Provention Bio, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
Mirae Asset Global Investments's Provention Bio, Inc. Common Stock position peaked at $722K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Mirae Asset Global Investments's 13F filing for Q2 2023, filed 10 Aug 2023.